Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria
Public ClinicalTrials.gov record NCT05936567. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy, and Safety Study of Povorcitinib in Participants With Chronic Spontaneous Urticaria
Study identification
- NCT ID
- NCT05936567
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Incyte Corporation
- Industry
- Enrollment
- 136 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Povorcitinib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 30, 2023
- Primary completion
- Feb 27, 2025
- Completion
- Oct 8, 2025
- Last update posted
- Mar 11, 2026
2023 – 2025
United States locations
- U.S. sites
- 22
- U.S. states
- 15
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Center of Alabama | Birmingham | Alabama | 35209 | — |
| Cahaba Dermatology | Birmingham | Alabama | 35244 | — |
| Foothills Research Center | Scottsdale | Arizona | 85260 | — |
| Little Rock Allergy Asthma, Pa Clinical Research Center Lraac | Little Rock | Arkansas | 72205 | — |
| Arkansas Research Trials | North Little Rock | Arkansas | 72117 | — |
| First Oc Dermatology | Fountain Valley | California | 92708 | — |
| Newport Native Md | Newport Beach | California | 92663 | — |
| Antelope Valley Clinical Trials Lancaster Office | Palmdale | California | 93551 | — |
| Allergy and Asthma Consultants, Pc | Redwood City | California | 94063 | — |
| Treasure Valley Medical Research | Boise | Idaho | 83706 | — |
| Midwest Allergy Sinus Asthma, Sc | Normal | Illinois | 61761 | — |
| Delricht Research | New Orleans | Louisiana | 70115 | — |
| David Fivenson, Md, Dermatology, Pllc | Ann Arbor | Michigan | 48103 | — |
| Revival Research Institute, Llc Troy | Troy | Michigan | 48084 | — |
| The Clinical Research Center Crc, Llc | St Louis | Missouri | 63141 | — |
| Optimed Research Ltd | Columbus | Ohio | 43235 | — |
| Central Sooner Research | Oklahoma City | Oklahoma | 73170 | — |
| Vital Prospects Clinical Research Institute, Pc Vpcri | Tulsa | Oklahoma | 74136 | — |
| Dermdox Center For Dermatology | Sugarloaf | Pennsylvania | 18249 | — |
| Allergy and Asthma Center of Charleston | Charleston | South Carolina | 29407 | — |
| Rainey and Finklea Dermatology | San Antonio | Texas | 78212 | — |
| Bellingham Asthma, Allergy Immunology Clinic | Bellingham | Washington | 98225 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05936567, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 11, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05936567 live on ClinicalTrials.gov.